Nitisinone, a drug that is already used to treat two genetic diseases, could be repurposed to control the spread of malaria, ...

Malaria parasites undergo an extensive metamorphosis after invasion of erythrocytes. This induces an increase in the surface ...

A single dose of the drug nitisinone could render a person’s blood lethal to mosquitoes for five days, modelling suggests.

Malaria has been described as Nigeria’s most enduring public health challenge. Caused by parasites of the genus Plasmodium, ...

Johns Hopkins biomedical engineers Mihaela Pertea and Sri Sarma honored for outstanding contributions to engineering and ...

Immunic, Inc. , a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced participation ...

Malaria remains a major global health threat, with more than 250 million cases and 600,000 deaths in 2024 – over 90% of them ...

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of the QIAprep&amp Plasmodium Kit and two companion assays to support malaria research and surveillance efforts.

Recent findings suggest that chimpanzees have evolved unique genetic mechanisms that help them resist malaria, offering ...

Aizawl: While most districts in Mizoram are making significant progress toward achieving the central govt's target of zero ...

A new drug that makes human blood poisonous to mosquitoes could be a vital new tool to fight malaria. The drug, called nitisinone, kills mosquitos but is not toxic to humans.A drug used to treat a ...